1 alysis to account for informative censoring (
cohort analysis).
2 e interval, 0.11-0.79; P = 0.016 in combined
cohorts analysis).
3 ransplant outcome in a uni- and multilateral
cohort analysis.
4 Retrospective, longitudinal
cohort analysis.
5 to 2004 were included in this retrospective
cohort analysis.
6 The study was a retrospective
cohort analysis.
7 xaminations were included in a retrospective
cohort analysis.
8 Sample to conduct a retrospective nationwide
cohort analysis.
9 Poisson regression modeling in an age-period-
cohort analysis.
10 comparison women were identified for a case-
cohort analysis.
11 ogic outcomes were analyzed in retrospective
cohort analysis.
12 ECMO using a propensity score-matched (1:1)
cohort analysis.
13 along with 4032 subcohort members in a case-
cohort analysis.
14 C or TMT by using a propensity score matched-
cohort analysis.
15 We conducted a retrospective
cohort analysis (
2005-2011) of 695 deliveries involving
16 In an unmatched
cohort analysis (
3009 in the appendicectomy cohort and 1
17 ways: firstly replicating the trial reported
cohort analysis acknowledging pairing of observations, b
18 Prospective
cohort analysis among 4207 US men and women of a mean ag
19 However, in a
cohort analysis and after adjustment for confounders, a
20 ease (CVD) were included in this prospective
cohort analysis and followed for an average of 6.7 years
21 Retrospective
cohort analysis and matched pairs analysis with historic
22 d albuminuria; in a propensity score-matched
cohort analysis;
and in sensitivity analyses.
23 An age
cohort analysis based on numbers of infected cattle, dos
24 In the
cohort analysis,
birth weight of <2,500 g was associated
25 In a second matched
cohort analysis,
children who were undervaccinated becau
26 Cohort analysis comparing patients with short-term (<5 y
27 Age-period-
cohort analysis confirmed a significant increase in whit
28 The matched
cohort analysis demonstrated that the BCRL group had sig
29 This large-
cohort analysis demonstrates that although institutional
30 Estimates of rho from
cohort analysis differ from those that consider the whol
31 This exploratory
cohort analysis grouped patients by baseline and most re
32 In this propensity score-matched
cohort analysis in a US commercially insured population
33 ducted a single-center retrospective matched-
cohort analysis in adult patients with Enterobacteriacea
34 We performed a retrospective
cohort analysis in patients with high-risk AML who recei
35 The authors conducted a prospective
cohort analysis in the Women's Health Study (1992-2004),
36 13 of 61; 23%), we performed a retrospective
cohort analysis in which patients with CF and PTLD were
37 Our
cohort analysis included 170 034 people: 112 936 in the
38 Prospective, population-based
cohort analysis including 21870 participants (20163 free
39 challenges the theory that Frost discovered
cohort analysis independently and gave it its name.
40 This pooled
cohort analysis merged individual data from 48286 partic
41 In another observational
cohort analysis (
n = 12,866), the percentage risk reduct
42 c women were sampled for inclusion in a case-
cohort analysis (
n=564 comprising the subcohort, n=479 e
43 We undertook a population-based
cohort analysis,
obtaining data from every deceased-dono
44 A
cohort analysis of 10 additional cancers included 236,50
45 A
cohort analysis of 1193 patients having acute ischemic s
46 We carried out a
cohort analysis of 121,422 children with anonymised link
47 adult patients, we conducted a retrospective
cohort analysis of 1286 patients aged >/=18 years who un
48 A longitudinal, retrospective
cohort analysis of 13,223 articles (5999 treatment, 7224
49 We undertook a retrospective
cohort analysis of 137 kidney-pancreas transplant recipi
50 Retrospective
cohort analysis of 15,015 patients with type 1 or 2 diab
51 We carried out a retrospective
cohort analysis of 151,891 live-born singleton infants w
52 lity, and hospitalization in a retrospective
cohort analysis of 1671 incident hemodialysis patients w
53 We conducted a retrospective
cohort analysis of 18 patients who had anti-CASPR2 antib
54 Retrospective
cohort analysis of 184875 patients with an infection-rel
55 We conducted a retrospective
cohort analysis of 197 MDR tuberculosis patients treated
56 A prospective
cohort analysis of 2 groups was performed.
57 We performed a prospective
cohort analysis of 220 white Caucasoid patients admitted
58 Conversely, a
cohort analysis of 245 case intervals and 3,896 noncase
59 Cohort analysis of 26,638 stage I to III colorectal canc
60 DESIGN, SETTING, AND PATIENTS: Retrospective
cohort analysis of 317,643 patients (n = 579,504 admissi
61 dence of type 2 diabetes (T2D).A prospective
cohort analysis of 3349 individuals who were free of dia
62 Retrospective
cohort analysis of 3433 patients (aged 50-69 years) who
63 In the matched
cohort analysis of 396,810 patients treated by IMG and U
64 Retrospective
cohort analysis of 4253 patients aged 50 to 69 years who
65 om the United Kingdom were used to conduct a
cohort analysis of 491,516 women.
66 DESIGN, SETTING, AND PATIENTS: Retrospective
cohort analysis of 52,791 pediatric admissions to 54 U.S
67 Health Study (1980-2004); and a prospective
cohort analysis of 69,693 participants without prior car
68 Prospective propensity-matched
cohort analysis of 7 newly introduced cardiovascular dev
69 The propensity scores matched
cohort analysis of 786 patients without a wait time foun
70 We conducted a historical prospective
cohort analysis of a 1.1-million-member, integrated, man
71 Society Adult Patient Database and a nested
cohort analysis of a single center.
72 We performed a retrospective
cohort analysis of adults hospitalized in the United Sta
73 We performed a retrospective
cohort analysis of all consecutive adult patients who un
74 In this birth
cohort analysis of all-cause dementia incidence in perso
75 Descriptive study with age-period-
cohort analysis of cancer registration data from the Nat
76 This was a retrospective
cohort analysis of children treated on the Intergroup Rh
77 METHODS AND We performed a retrospective
cohort analysis of claims data for Medicaid beneficiarie
78 Retrospective longitudinal
cohort analysis of claims data from women 50 years or ol
79 Inception
cohort analysis of data from 413 patients with early, un
80 A prospective
cohort analysis of data from consecutive ICU patients ad
81 Retrospective
cohort analysis of data from the FACS (follow-up after c
82 We did a retrospective
cohort analysis of data from the NLST, a randomised, mul
83 Retrospective observational
cohort analysis of data gathered concurrently with patie
84 of this study was to perform a case-matched
cohort analysis of dual kidney transplantation (DKT) fro
85 A retrospective
cohort analysis of elective operations from 2002 to 2008
86 Observational
cohort analysis of geocoded longitudinal electronic heal
87 A case-
cohort analysis of human immunodeficiency virus (HIV)-in
88 Retrospective
cohort analysis of Medicare claims for 2002-2007, focusi
89 A retrospective longitudinal
cohort analysis of national Medicaid claims data was con
90 An international multicentre
cohort analysis of outpatients with bronchiectasis from
91 We conducted a retrospective
cohort analysis of pairs of deceased donor kidney transp
92 We performed a retrospective
cohort analysis of patients transplanted at our center w
93 To assess the impact of DOX, a contemporary
cohort analysis of patients treated from 1975 to 1990 wa
94 To assess the impact of IF, a contemporary
cohort analysis of patients treated from 1990 to 2003 wa
95 In this retrospective
cohort analysis of patients treated with either nafcilli
96 We performed a historical
cohort analysis of pediatric CF patients in the United S
97 uate such steroid avoidance, a retrospective
cohort analysis of pediatric kidney transplant recipient
98 In a retrospective
cohort analysis of pediatric patients, we evaluated the
99 ucted two types of analysis: 1) a historical
cohort analysis of singleton live births in New Jersey h
100 hma complicating pregnancy, using historical
cohort analysis of singleton live deliveries in New Jers
101 In a
cohort analysis of the ADVANCE (Action in Diabetes and V
102 We then performed a case-
cohort analysis of the effects of hepatitis B viral fact
103 A retrospective
cohort analysis of the incidence of cancer in older adul
104 A retrospective
cohort analysis of the Truven Health MarketScan Database
105 6), and a 1936 lecture on the age, time, and
cohort analysis of tuberculosis mortality.
106 Survivor Study, we performed a retrospective
cohort analysis of validated cases of congenital anomali
107 To validate associations, we performed a kin-
cohort analysis on the 14 704 first-degree relatives of
108 of baseline-matched subgroups concurred with
cohort analysis (
P = .009 for comparison of peginterfero
109 r analysis (p for trend = 0.009) than in the
cohort analysis (
p for trend = 0.18).
110 the CSGA cohort (P= .008), and in a combined
cohort analysis (
P= .003).
111 his prospective nonrandomized interventional
cohort analysis performed at a tertiary referral center
112 For the retrospective
cohort analysis,
raising vitamin D levels from <20 to >/
113 However, the Twins
cohort analysis revealed a powerful role for common envi
114 Birth
cohort analysis showed diminishing incidence rates throu
115 The birth-
cohort analysis showed peak incidence rates in the 1880-
116 In the
cohort analysis,
smoking at baseline did not predict the
117 ic failure based on a Prentice weighted case-
cohort analysis stratified by study.
118 ncer (OnCoRe) was a propensity-score matched
cohort analysis study, that included patients of all age
119 For the
cohort analysis,
subject mother-infant dyads were identi
120 Interpretation of this
cohort analysis suggests that LET improves DFS and dista
121 Wade Hampton Frost developed methods for
cohort analysis that formed the early basis for adjustme
122 We conducted a prospective
cohort analysis that involved 151 Kenyan sex workers.
123 The authors identified 1 large, matched
cohort analysis that reported greater weight loss with s
124 In this large retrospective
cohort analysis there was no evidence of any increased r
125 In each
cohort analysis,
there is substantial stability gained i
126 In the
cohort analysis,
there was no increased risk of multiple
127 In the
cohort analysis,
there were 2564 AMD subjects not on a v
128 We conducted a prospective
cohort analysis to characterize the human immune respons
129 We did a retrospective
cohort analysis to develop a continuous multivariable ri
130 We did a
cohort analysis to estimate and compare incidence of VTE
131 We conducted a population-based
cohort analysis to evaluate the incidence of chronic ren
132 e used both family-based and cross-sectional
cohort analysis to test for interactions between CD14 ge
133 Thus, we performed a prospective (case-
cohort) analysis to examine if persons who acquired type
134 The simulated full-
cohort analysis triggered a sustained alert for Fidelis
135 In a matched
cohort analysis,
undervaccinated children had lower outp
136 This population-based retrospective
cohort analysis used the National Cancer Database to sel
137 We conducted a retrospective
cohort analysis using a national registry of US medical
138 In this retrospective
cohort analysis using data from a large managed care dat
139 conducted a population-based, retrospective
cohort analysis using data from all primiparous women wh
140 We performed a
cohort analysis using data from the Cystic Fibrosis Foun
141 A retrospective
cohort analysis using Medicare fee-for-service patients
142 Observational intent-to-treat
cohort analysis using the Veterans Affairs Clinical Case
143 A case-
cohort analysis utilized 319 cases of selected causes of
144 We conducted a retrospective
cohort analysis utilizing healthcare claims data from th
145 A
cohort analysis was conducted among 6677 patients betwee
146 A
cohort analysis was conducted among participants in this
147 A retrospective
cohort analysis was conducted of data from January 1 to
148 A retrospective
cohort analysis was conducted of patients aged 21 to 84
149 A retrospective
cohort analysis was conducted of patients enrolled in th
150 A retrospective
cohort analysis was conducted using data collected betwe
151 An age-period-
cohort analysis was conducted using data on 18,295 exami
152 An observational
cohort analysis was conducted within the Surveillance, P
153 A birth-
cohort analysis was performed by calculating and compari
154 A matched-
cohort analysis was performed for radiation-associated a
155 A retrospective
cohort analysis was performed of randomly selected ACS p
156 A population-based
cohort analysis was performed of women who gave birth in
157 A retrospective
cohort analysis was performed on data from 124 patients,
158 A matched
cohort analysis was performed to account for confounders
159 A birth
cohort analysis was performed using data from the Third
160 A historical
cohort analysis was performed using histologic slides an
161 A birth
cohort analysis was performed, and survival rates over t
162 A
cohort analysis was performed.
163 A case-
cohort analysis was undertaken in a cohort of 56 837 wom
164 Propensity-matched
cohort analysis was used in sensitivity analyses.
165 Birth
cohort analysis was used to isolate age and cohort effec
166 For the international
cohort analysis,
we analysed clinical data from 705 pati
167 In a large retrospective
cohort analysis,
we analyzed data from the Swedish Regis
168 For this national retrospective
cohort analysis,
we extracted UK National Health Service
169 In this
cohort analysis,
we included data from patients with CML
170 In a retrospective
cohort analysis,
we included data from patients with CML
171 In this longitudinal
cohort analysis,
we monitored a group of premature child
172 In a prospective
cohort analysis,
we studied 3483 people with CKD in the
173 population-based, self-matched, longitudinal
cohort analysis,
we studied 8815 adults from Ontario, Ca
174 In this retrospective cross-sectional
cohort analysis,
we used 2005-2009 Medicare data on bene
175 In this prospective population-based
cohort analysis,
we used data from the population-based
176 Participants in our prospective
cohort analysis were from a randomised placebo-controlle
177 A retrospective
cohort analysis,
which controlled for risk factors ident
178 Retrospective propensity-matched
cohort analysis with accrual from September 1, 2012, to
179 A 1:1 propensity score matched
cohort analysis with multivariate analysis of effects wa
180 A one-to-one propensity-matched matched
cohort analysis with multivariate analysis of effects wa
181 We did a retrospective
cohort analysis,
within the Childhood Cancer Survivor St